Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol + dexmedetomidine versus propofol for anesthesia induction during electroconvulsive therapy
IRCT20231009059668N1Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in major depressive disorder (MDD) and bipolar disorder (BD) comparing Propofol + dexmedetomidine with Propofol (2 arms). Primary endpoints: Seizure duration, Recovery time and 3 more. Started Oct 2023; status: completed.
02
Drugs
propofoldexmedetomidine
03
Conditions
major depressive disorder (MDD)bipolar disorder (BD)
Beyond the preview
Go deeper on IRCT20231009059668N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231009059668N1.